Log in | Register

E-mail
Company Name

Perrigo Company Launches Labeling Initiative to Identify Gluten-free Products

Loading...
Perrigo Company today announced it will implement a labeling program to helpconsumers more clearly identify more than 200 of the company'sover-the-counter store-brand pharmaceuticals that are gluten-free, starting inJanuary 2010. Previously, the only way a consumer could verify apharmaceutical product as "gluten-free" was to call Perrigo directly. Now,consumers will be able to identify whether a Perrigo-supplied product is"gluten-free" simply by reading the product label.

Perrigo will be the first manufacturer to offer its customers the abilityto place gluten-free statements on a wide range of over-the-counterpharmaceutical products. The new initiative will include all of Perrigo'sbest-selling categories, such as pain relievers, cold and allergy, andantacids. The company already has more than 200 dietary supplements that arepart of a similar labeling program.

To support the gluten-free labeling initiative, Perrigo has instituted agluten-free assurance program. Perrigo's program is based on the acceptablethresholds of gluten (less than 20 parts per million) identified by the FDAfor the food industry. It is comprised of a gluten testing methodology for rawmaterials and products, as well as ongoing quality assurance for ingredientand formula changes.

Perrigo initiated the labeling program specifically in response to anincreasing market demand for gluten-free products. Questions from consumersregarding the gluten content of Perrigo-manufactured products have recentlyranked among the company's top call center inquiries.

Perrigo's Chairman and CEO Joseph C. Papa stated, "Our retail customerscan continue to rely on Perrigo to pinpoint and act on consumer trends. Thisincludes the growing list of individuals who need to know whether or not aproduct is gluten-free."

Gluten is a protein found in wheat, barley and rye. It is estimated thatin the United States, one in seven people have a gluten intolerance, and threemillion people suffer from celiac disease - when it is medically necessary toconsume only food and medicines that are gluten-free. In addition to thosediagnosed with celiac disease, millions more Americans, an estimated 15percent, suffer from varying levels of gluten intolerance.
Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Importance of Fundamentals

The Importance of Fundamentals

Aug 31 | Girish Malhotra, PE, President, EPCOT International

Globally, Johnson & Johnson is known for its integrity and product quality. A few years ago they handled the Tylenol situation extremely well and were commended for it. It is astounding that the year 2010 has become a nightmare for them.  

The Quality Control Unit: Invertebrates Need Not Apply

The Quality Control Unit: Invertebrates Need Not Apply

Aug 30 | The QA Pharm

The Quality Control Unit (QCU) is the only pharmaceutical function that has a job description codified in the CGMP regulations. Don’t you find this remarkable? In fact, an entire section is devoted to describing the responsibility of the QCU and how it is to operate within the organization—namely independently.        

Multimedia

Timothy Cote - Office of Orphan Products Development

Aug 13 | Root

From approving medicines to treating snake bites to Cystic Fibrosis - Dr. Tim Cote describes a special office at the FDA, designed to address needs of people with rare diseases. Timothy Cote, M.D. - Director, Office of Orphan Products Development

Charles River Labs On WuXi PharmaTech Acquisition

Charles River Labs On WuXi PharmaTech Acquisition

May 25 | Video

Charles Rivers Laboratories International Chief Officer talks about the recent WuXi PharmaTech acquisition

Biogen Idec - 2010 Facility of the Year Award Winner - Operational Excellence

Biogen Idec - 2010 Facility of the Year Award Winner - Operational Excellence

Apr 27 | Video

Peter Flinn, Biogen Idec's Senior Director, Global Project Engineering talks to Pharmaceutical Processing's Editor-In-Chief Mike Auerbach about the company's Large-Scale Manufacturing Technology Map Project in Research Triangle Park, North Carolina. The project won the 2010 Operational...

MannKind Corporation - 2010 Facility of the Year Award Winner - Equipment & Process Innovation

MannKind Corporation - 2010 Facility of the Year Award Winner - Equipment & Process Innovation

Apr 28 | Video

Juergen Martens, Ph,D. MannKind Corporation's Corporate Vice President and Chief Technical Officer talks to Pharmaceutical Processing's Editor-In-Chief Mike Auerbach durng INTERPHEX2010 about the company's Technosphere Insulin Manufacturing Facility located in Danbury, Connecticut. The...